Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 3 17Phase NA 5Phase 4 5Phase 2/3 2Phase 1/2 2

Status

Completed 3Unknown 1Recruiting 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 2Sarcoma 1Other hematologic neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Sarcoma 1Prostatic Neoplasms 1Primary Care 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Hematologic Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 258Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 145Surgical Procedures, Operative 134Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Radiotherapy, Intensity-Modulated 79Colonoscopy 79Specimen Handling 78Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase NA × Interventional × Darbepoetin alfa × Clear all
NCT06184867 2026-03-06

CATALYST

Rutgers, The State University of New Jersey

Phase NA Completed
50 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07130487 2025-11-25

Project CARE: CAncer Risk Evaluation

Rutgers, The State University of New Jersey

Phase NA Recruiting
210 enrolled

Primary Care

NCT00283621 2018-11-07

Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide

M.D. Anderson Cancer Center

Phase NA Completed
51 enrolled
Sarcoma

Sarcoma

NCT00355407 2009-03-13

Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation

Dana-Farber Cancer Institute

Phase NA Completed
31 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT00309920 2009-02-09

Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer

National Cancer Institute (NCI)

Phase NA Unknown
1,234 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡